“… Decreased MDA level, increase CAT activity and GSH level | 113 | | Methanolic extracts from C. siphonanthus | In vitro | Thiocyanate method, DPPH-radicals | 0–120 mg/ml | Scavenging lipid peroxide (IC 50 = 8 mg/ml) and DPPH radicals (IC 50 = 7 mg/ml) | 114 |
Anti-cancer activity | Methanolic extract from C. serratum | In vivo | DMBA-induced skin tumorigenesis in male mice | 300, 600 and 900 mg/kg, i.g. | Curtailed tumor development | 115 , 116 |
| Methanolic extract from C. serratum | In vivo | DLA cell model | 100 and 200 mg/kg | Reduced skin papilloma incidence and multiplicity | 117 |
| Cryptojaponol, fortunin E, 12-methoxy-6,11,14,16-tetrahydroxy-17(15→16)-abeo-5,8,11,13-abietatetraen-3,7-dione | In vitro | HL-60, SMMC-7721, lA-549, MCF-7 cell lines | 1.8–5.0 μM | Exhibited cytotoxicity | 89 |
| Compounds 45, 70, 76, 78, 81, and 82 | In vitro | BGC-823, Huh-7, KB, KE-97, and Jurkat | 0.83–50.99 μM | Exhibited cytotoxicity | 41 |
| Total flavonoids from C. Bungei | In vitro | HepG 2 | 0.025–250 μg/ml | Inhibited HepG 2 cells proliferation | 119 |
| Trichotomone | In vitro | A549, Jurkat, BGC-823 and 293T WT | 7.51–19.38 μM | Exhibited cytotoxicity | 43 |
| Compounds 240 and 243 | In vitro | Hela cell | 28.92–35.67 μg/ml | Exhibited moderate cytotoxicity | 82 |
Anti-bacterial activity | Methanolic extract from C. siphonanthus | In vitro | Klebsiella pneumoniae , Proteus mirabilis , Salmonella typhi , ... |
…”